BSE filing, NSE: CONTCHM. Summary written from the filing by ALFA Finder's alert engine.
Continental Chemicals Ltd: key numbers
- Share price
- ₹54.72
- Market cap
- ₹12.31 Cr
- Revenue (annual)
- ₹0.26 Cr
- Net profit (annual)
- ₹0.51 Cr
- P/E (TTM)
- 25.4×Sector 22.9×
- Promoter holding
- 61.57%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Continental Chemicals Ltd
All →Continental Chemicals Board Meeting Date
Continental Chemicals schedules a board meeting on 05 Nov 2026 to consider unaudited standalone half-year financial results for September 2026. The trading window closes 01 Oct to 07 Nov 2026.
Continental Chemicals Other Announcement
The company submitted its quarterly shareholding pattern under Regulation 31(1)(b) for the quarter ended September 30, 2026.
Continental Chemicals Annual General Meeting
Continental Chemicals Ltd held its 41st Annual General Meeting via video conferencing on September 18, 2026. The meeting transacted ordinary business items as per the notice.
Continental Chemicals Annual General Meeting
Continental Chemicals Limited announced a book closure from September 12 to September 18, 2026. This period supports the company's upcoming Annual General Meeting and shareholder e-voting.
Continental Chemicals Annual Report
Continental Chemicals Limited has submitted its 41st Annual Report for the Financial Year 2025-2026. The filing includes the company's corporate information and a note from the Managing Director.
Continental Chemicals Board Meeting Outcome
Continental Chemicals Ltd's board meeting outcomes include approving the Draft Board’s Report and scheduling the 41st AGM for September 18, 2026.
Other board meeting date announcements
All →Patel Engineering Board Meeting Date
Patel Engineering has scheduled its Board meeting for November 5, 2026, to approve Q1 and H1 FY27 unaudited results. No financial figures or decisions are reported in this advance notice.
GKB Ophthalmics Board Meeting Date
GKB Ophthalmics scheduled its Board Meeting for November 12, 2026. The meeting will consider approving unaudited results for the September 30, 2026 quarter and half year.
Bombay Oxygen Investments Board Meeting Date
Board meeting scheduled for Nov 6, 2026 to approve Q1 and H1 FY27 unaudited results. Trading window closed for insiders Oct 1–Nov 8, 2026.
OCCL Board Meeting Date
OCCL Ltd has scheduled its Board meeting for 6 November 2026 to consider Q1 FY27 unaudited results and a possible interim dividend. The trading window for designated persons closed from 1 October 2026.
TCM Board Meeting Date
TCM Limited intimated a Board meeting for 06/11/2026 to approve Q2 FY27 results. The trading window will reopen 48 hours after the results declaration.
Mercury Laboratories Board Meeting Date
Mercury Laboratories scheduled its Board meeting for November 5, 2026, to approve Q2/H1 FY27 results. Trading window remains closed until 48 hours post-announcement.